Print Page   |   Contact Us   |   Sign In
McDermott Will & Emery

McDermott Will & Emery

McDermott Will & Emery is a premier international law firm with a diversified business practice including extensive work in healthcare law. They understand the issues faced by corporate decision makers because many of their lawyers have held key government and in-house positions. They understand how economic, social and political issues affect operations because their lawyers have navigated the complex business and regulatory environment themselves. Outstanding client service is a cornerstone of their practice. Click here to learn more

The Long-Term Impact of COVID-19 on Corporate Governance
This Governing Health series examines how traditional governance practices may change and how boards of directors can position themselves to proactively support their organizations now and as they recover from the COVID-19 shutdown. Throughout the series, we’ll take increasingly closer looks at important aspects of corporate governance that will be shaped by this global crisis.

Are you prepared to re-evaluate your governance policies and procedures? Our team explores 10 areas boards should review in a post-COVID-19 world. Read more

Jarrard Inc., The Chartis Group and McDermott Will & Emery held a webinar to talk about the role of the board during crises.
The presenters included The Governance Institute faculty and partners. The webinar recording is available here

Additionally, here are a few resources to help you through this time:

Special Report: Antitrust Litigation Update for Health Care Providers
This Special Report highlights notable trends in antitrust litigation involving health care providers over the past two and a half years. Our complimentary update identifies the types of cases filed against providers, who is filing them, case results and currently pending cases to watch.   Click here to download

Boards Should Note Important New Compliance Program Guidance: Evaluation of Corporate Compliance Programs

The audit & compliance committees of hospitals and health systems will want to review the new compliance program guidance issued by the Fraud Section of the Department of Justice. The “Evaluation of Corporate Compliance Programs” provides an exceptionally practical set of benchmarks against which the audit & compliance committee, in consultation with the general counsel and the chief compliance officer, can evaluate the effectiveness of the health system’s compliance program. Click here to read more and view a PDF of the guidance

McDermott Will & Emery Governing Health Podcasts
Governing Health brings director-level education out of the boardroom with succinct, engaging, issue-based episodes available at the director's convenience. When tightly packed board agendas preclude adequate ongoing education for health care directors, this monthly series moderated by McDermott governance partner Michael W. Peregrine fills the gap. Click here to listen to podcasts

Publications from McDermott Will & Emery:

Addressing Conflicts of Interest: It’s a Whole New Ballgame (vidcast)
2018 Health Care Systems Governance Trends Mid-Year Top 10 (PDF)

Other Resources from McDermott Will & Emery and Kaufman Hall:

Surviving Disruption: A Roadmap for Health Care Governance